All articles by Jenna Philpott

Jenna Philpott

Jenna Philpott is a trainee healthcare and pharmaceutical reporter. Coming from a scientific background, Jenna has expertise in biochemistry, genetics and cancer science. Jenna previously wrote freelance articles focused on oncology and healthcare.

Proximie announce blueprint to digitalise operating rooms at Slush 

Proximie’s software development kit (SDK) will be used by surgeons, healthcare organisations and medical device companies to advance the field of surgery.

Dimension Inx treats first patients with 3D regenerative bone graft

The FDA-approved 3D-printed bone graft has made its clinical debut in jaw surgeries performed in the US and Germany.

Philips launches new MR Smart Fit coils at RSNA

Philips has launched several devices at the RSNA as the company recovers from mass device recalls this year.

Pristine Surgical launch Summit arthroscope in US

The full market release in the US comes after the FDA 510(K) cleared device was first used in April at the Southern California Orthopedic Institute.

SHL Telemedicine launches SmartHeart membership in US 

Emergency room visits for post-myocardial infarction patients were down 27.5% after using the SmartHeart device.

Lunit’s AI diagnosis tool matches accuracy of radiologists

The findings match the accuracy of radiologists in detecting breast cancer when the AI threshold is appropriately set.

PostEra joins forces with Amgen for AI drug discovery

The deal involves upfront funding, milestone payments and royalties on approved products coming out from the collaboration.

Avation Medical confirm safety and efficacy data on smart bladder control system

The non-invasive Vivally device uses neuromodulation to block electric signals along nerves to the brain that encode urinary urges.

Theranica and Dr Reddy’s team up to distribute Nerivio in Europe 

The commercial agreement includes licensing fees and additional payments in return for the exclusive rights to market Nerivio in several European countries.

InMed AI secures FDA 510(k) clearance for NeuroShield

FDA 510(k) clearance has been given to InMed AI’s NeuroShield imaging device, aiding physicians in diagnosing neurodegenerative diseases.